NO165238C - Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater.

Info

Publication number
NO165238C
NO165238C NO863834A NO863834A NO165238C NO 165238 C NO165238 C NO 165238C NO 863834 A NO863834 A NO 863834A NO 863834 A NO863834 A NO 863834A NO 165238 C NO165238 C NO 165238C
Authority
NO
Norway
Prior art keywords
derivatives
preparation
therapeutically active
new therapeutically
analogy procedure
Prior art date
Application number
NO863834A
Other languages
English (en)
Norwegian (no)
Other versions
NO863834L (no
NO165238B (no
NO863834D0 (no
Inventor
Michel Follet
Marc Bonato
Original Assignee
Conseils De Rech Et D Appl Sci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseils De Rech Et D Appl Sci filed Critical Conseils De Rech Et D Appl Sci
Publication of NO863834D0 publication Critical patent/NO863834D0/no
Publication of NO863834L publication Critical patent/NO863834L/no
Publication of NO165238B publication Critical patent/NO165238B/no
Publication of NO165238C publication Critical patent/NO165238C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO863834A 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater. NO165238C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858523776A GB8523776D0 (en) 1985-09-26 1985-09-26 Catechol derivatives

Publications (4)

Publication Number Publication Date
NO863834D0 NO863834D0 (no) 1986-09-25
NO863834L NO863834L (no) 1987-03-27
NO165238B NO165238B (no) 1990-10-08
NO165238C true NO165238C (no) 1991-01-16

Family

ID=10585770

Family Applications (2)

Application Number Title Priority Date Filing Date
NO863835A NO170415C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater
NO863834A NO165238C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO863835A NO170415C (no) 1985-09-26 1986-09-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske katekolderivater

Country Status (28)

Country Link
US (2) US4699919A (es)
JP (2) JPS6284055A (es)
AR (2) AR242559A1 (es)
AT (2) AT396469B (es)
BE (2) BE905433A (es)
CA (2) CA1318686C (es)
CH (2) CH668261A5 (es)
DE (2) DE3632824A1 (es)
DK (2) DK168334B1 (es)
DZ (2) DZ990A1 (es)
ES (2) ES2001705A6 (es)
FI (2) FI84480C (es)
FR (4) FR2587698B1 (es)
GB (3) GB8523776D0 (es)
HK (2) HK91289A (es)
IE (2) IE59478B1 (es)
IT (2) IT1235761B (es)
LU (2) LU86590A1 (es)
MA (2) MA20780A1 (es)
MY (2) MY103521A (es)
NL (2) NL189334C (es)
NO (2) NO170415C (es)
OA (2) OA08417A (es)
PT (2) PT83437B (es)
SE (2) SE464522B (es)
SG (1) SG65889G (es)
TN (2) TNSN86135A1 (es)
ZA (2) ZA866905B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927629A (en) * 1987-12-17 1990-05-22 Huntington Medical Research Institutes Relaxation of smooth vascular muscle
AU1520699A (en) 1997-11-07 1999-05-31 Johns Hopkins University, The Methods for treatment of disorders of cardiac contractility
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
RS58438B1 (sr) 2011-07-22 2019-04-30 Massachusetts Inst Technology Aktivatori klase i histonskih deacetilaza (hdacs) i njihova primena

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549118A (en) * 1949-10-05 1951-04-17 Us Rubber Co Vulcanized rubber and method of preserving same
CH301688A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301687A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301691A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
US3148997A (en) * 1963-01-04 1964-09-15 Dow Chemical Co Catechol compounds in improving clays and clay-containing materials
US3274257A (en) * 1963-06-17 1966-09-20 Dow Chemical Co Synthesis of (alkylthio) phenols
US3282979A (en) * 1963-06-17 1966-11-01 Dow Chemical Co Phenolic thioethers
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
US3751483A (en) * 1971-10-13 1973-08-07 Crown Zellerbach Corp Phenolic thioethers and process for preparing same
GB1428110A (en) * 1972-05-30 1976-03-17 Reckitt & Colmann Prod Ltd Pharmaceutical antihypertensive and vasodilator compositions
JPS506340A (es) * 1973-05-16 1975-01-23
DE2644591A1 (de) * 1976-10-02 1978-04-06 Bayer Ag Verfahren zur herstellung von arylsulfoniumsalzen
AU548253B2 (en) * 1981-05-11 1985-12-05 Pierre Fabre S.A. Benzoxepine derivatives and sulphur and nitrogen analogues thereof
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
JPS60260532A (ja) * 1984-06-07 1985-12-23 Yamanouchi Pharmaceut Co Ltd 新規カテコ−ル誘導体
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers

Also Published As

Publication number Publication date
HK91289A (en) 1989-11-24
AT402070B (de) 1997-01-27
DE3632824A1 (de) 1987-04-02
FI84480B (fi) 1991-08-30
FI863742A0 (fi) 1986-09-16
PT83437B (pt) 1988-07-29
ES2001440A6 (es) 1988-05-16
AR241702A1 (es) 1992-11-30
IE59479B1 (en) 1994-03-09
NL8602382A (nl) 1987-04-16
NO863834L (no) 1987-03-27
IE862532L (en) 1987-03-26
LU86590A1 (fr) 1987-01-22
SE8603792L (sv) 1987-03-27
DE3632824C2 (es) 1992-04-30
FR2587699B1 (fr) 1988-11-10
ES2001705A6 (es) 1988-06-01
FR2587703A1 (fr) 1987-03-27
PT83436A (en) 1986-10-01
FR2587702B1 (fr) 1988-11-04
GB8523776D0 (en) 1985-10-30
FI87646B (fi) 1992-10-30
GB8623074D0 (en) 1986-10-29
FR2587699A1 (fr) 1987-03-27
FI84480C (fi) 1991-12-10
JPS6284055A (ja) 1987-04-17
OA08417A (fr) 1988-06-30
IE59478B1 (en) 1994-03-09
NO170415C (no) 1992-10-14
NL189334C (nl) 1993-03-16
ATA257386A (de) 1993-01-15
MA20779A1 (fr) 1987-04-01
NO165238B (no) 1990-10-08
NL8602383A (nl) 1987-04-16
MY105863A (en) 1995-02-28
FI863743A0 (fi) 1986-09-16
FR2587703B1 (fr) 1988-11-04
CH668261A5 (fr) 1988-12-15
BE905433A (fr) 1987-03-16
JPS6284080A (ja) 1987-04-17
FI87646C (fi) 1993-02-10
JPH0482129B2 (es) 1992-12-25
TNSN86135A1 (fr) 1990-01-01
MA20780A1 (fr) 1987-04-01
FI863742A (fi) 1987-03-27
GB2181431B (en) 1989-09-20
DK457486D0 (da) 1986-09-25
FR2587698A1 (fr) 1987-03-27
TNSN86134A1 (fr) 1990-01-01
CA1318686C (en) 1993-06-01
PT83436B (pt) 1988-07-29
US5013756A (en) 1991-05-07
ATA257486A (de) 1996-06-15
NO863835D0 (no) 1986-09-25
IT1235760B (it) 1992-09-28
ZA866905B (en) 1987-04-29
DK168334B1 (da) 1994-03-14
CH668421A5 (fr) 1988-12-30
NL189410B (nl) 1992-11-02
PT83437A (en) 1986-10-01
AT396469B (de) 1993-09-27
DK165115B (da) 1992-10-12
GB8623075D0 (en) 1986-10-29
LU86591A1 (fr) 1987-01-22
SE8603792D0 (sv) 1986-09-10
HK46190A (en) 1990-06-22
SE467053B (sv) 1992-05-18
GB2189782A (en) 1987-11-04
IT8621836A0 (it) 1986-09-26
NO863835L (no) 1987-03-27
GB2189782B (en) 1989-04-12
FR2587702A1 (fr) 1987-03-27
NL189410C (nl) 1993-04-01
ZA866906B (en) 1987-04-29
US4699919A (en) 1987-10-13
NO863834D0 (no) 1986-09-25
DZ990A1 (fr) 2004-09-13
IT8621837A0 (it) 1986-09-26
GB2181431A (en) 1987-04-23
DK457486A (da) 1987-03-27
DE3632841C2 (es) 1992-06-11
MY103521A (en) 1993-07-31
DK457386A (da) 1987-03-27
FI863743A (fi) 1987-03-27
DK165115C (da) 1993-03-01
CA1278299C (en) 1990-12-27
SE464522B (sv) 1991-05-06
OA08416A (fr) 1988-06-30
DZ991A1 (fr) 2004-09-13
SE8603793D0 (sv) 1986-09-10
AR242559A1 (es) 1993-04-30
JPH0417956B2 (es) 1992-03-26
BE905432A (fr) 1987-03-16
IT1235761B (it) 1992-09-28
FR2587698B1 (fr) 1989-04-28
IE862533L (en) 1987-03-26
NO170415B (no) 1992-07-06
DK457386D0 (da) 1986-09-25
SG65889G (en) 1990-01-26
SE8603793L (sv) 1987-03-27
DE3632841A1 (de) 1987-04-02

Similar Documents

Publication Publication Date Title
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO170023C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alfa-glucosidaseinhibitorer
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO169485C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, substituerte benzamidderivater
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO165635C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive kinolinderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO165238C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive katekolderivater.
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.